Chemomab Therapeutics Ltd. Liabilities Assumed
Chemomab Therapeutics Ltd. (CMMB) reported Liabilities Assumed of $0 for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-28.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2024-03-28
| Period end | Liabilities Assumed 12 month |
|---|---|
| 2023-12-31 | $0.00 20-F · filed 2024-03-28 |
| 2022-12-31 | $0.00 20-F · filed 2024-03-28 |
| 2021-12-31 | $49.00K 20-F · filed 2024-03-28 |